Metastatic papillary thyroid cancer
Initial diagnosis: 1993 - 8 years old

"BostonGene Genomic testing can help save your life like it has saved mine."
Initial diagnosis
1994 - 1999
iodine therapy
Lung, jaw, skull metastases
Internal hospital IHC test. NTRK fusion negative
Tumor Portrait™
RNA-seq NTRK fusion positive
Complete Response
Started Larotrectinib

In 1993 at just eight years old, a lump appeared on Mariela’s neck. Initially, Mariela’s parents wanted to have the lump removed due to the severe pain it was causing their daughter. However, a biopsy soon revealed that she had thyroid carcinoma. Shortly after her diagnosis, a family friend referred Mariela to a leading academic cancer center in the United States. Her doctor, a physician in the Department of Endocrine and Division of Internal Medicine, recommended surgery, and Mariela underwent a successful thyroidectomy at the age of nine. After the surgery, she was treated with radioactive iodine therapy (RAI), and over the next few years, she received three more rounds of RAI.

In 2020, Mariela noticed the growth of two lumps on her forehead and jaw. Leaving her feeling anxious, her doctor, a physician in the Department of Endocrine Neoplasia and Hormonal Disorders and Division of Internal Medicine at her treating hospital, proceeded to find out why she was suffering from both pain and numbness in her face. After a series of tests, multiple lesions were found in her lungs, left jaw, and skull. Several tests failed to detect anything for use in designing an appropriate course of treatment. Her doctor was determined to find treatment options and sent tissue samples from her 1994 thyroid removal tissue and tissue from the tumor removal from her left frontal skull to BostonGene for genomic testing. BostonGene’s Tumor Portrait™ test identified an NTRK3 fusion (ETV6-NTRK3). Based on these findings, Mariela’s doctor started her on an FDA-approved NTRK inhibitor called larotrectinib.

Mariela has these words of support for anyone facing the same challenges:

“I encourage all cancer patients to undergo genomic testing. I am here today thanks to the wonderful collaboration between BostonGene, my doctor and the incredible team at the hospital. They found a genetic fusion that enabled my doctor to know exactly what treatment to start me on.”

— Mariela

Scans from May 2021 show that the cancer has stopped spreading and that the tumors are shrinking. Mariela intends to live a long and full life, stating: “BostonGene Genomic testing can help save your life like it has saved mine. I haven't let cancer define me. I am 36 years old, I run a successful business, and I am beating cancer. There is nothing that can stand in the way of me achieving my goals, if I Pivot, Change and Adapt.”

To safeguard the privacy of our patients, we have altered the images in order to present real cases from their treatment journeys .